CommercialAdministrativeMedium impact
05.00.77f, Implantable Cardioverter Defibrillators
Independence Blue Cross·Cardiology, Cardiothoracic Surgery, Internal Medicine·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Policy 05.00.77f for Implantable Cardioverter Defibrillators has been reissued effective April 1, 2026. This is a policy reissuance rather than a substantive change, but billing teams should review the updated policy document for any modifications to coverage criteria or requirements.
Action Required
By April 1, 2026: Billing team should review the updated Implantable Cardioverter Defibrillators policy 05.00.77f at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or billing guidelines. Update internal procedures and staff training materials accordingly.